Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and
Value-Based Pricing of Prescription Drugs Benefits Patients and Promotes Innovation americanprogress.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanprogress.org Daily Mail and Mail on Sunday newspapers.
Today the U.S. Food and Drug Administration (FDA or the Agency) published a long-awaited proposed rule to revise the regulatory definition of an in vitro diagnostic (IVD).